Moderna accuses FDA of shifting standard as agency refuses flu shot review
莫德纳指控FDA在拒绝审查其流感疫苗时“改变标准”

The FDA said it won’t review Moderna’s flu vaccine application, a surprise decision that the company is describing as a shifting of the standards for its pivotal trial well after it thought it had reached an agreement.
美国食品药品监督管理局(FDA)表示不会审评莫德纳流感疫苗的申报。此举出人意料，莫德纳称监管方在其认为已达成一致后，仍在关键性试验上改变了评估标准。